137 related articles for article (PubMed ID: 11005178)
1. Elimination of 7-aminoflunitrazepam and flunitrazepam in urine after a single dose of Rohypnol.
Negrusz A; Moore CM; Stockham TL; Poiser KR; Kern JL; Palaparthy R; Le NL; Janicak PG; Levy NA
J Forensic Sci; 2000 Sep; 45(5):1031-40. PubMed ID: 11005178
[TBL] [Abstract][Full Text] [Related]
2. Deposition of 7-aminoflunitrazepam and flunitrazepam in hair after a single dose of Rohypnol.
Negrusz A; Moore CM; Hinkel KB; Stockham TL; Verma M; Strong MJ; Janicak PG
J Forensic Sci; 2001 Sep; 46(5):1143-51. PubMed ID: 11569557
[TBL] [Abstract][Full Text] [Related]
3. Highly sensitive micro-plate enzyme immunoassay screening and NCI-GC-MS confirmation of flunitrazepam and its major metabolite 7-aminoflunitrazepam in hair.
Negrusz A; Moore C; Deitermann D; Lewis D; Kaleciak K; Kronstrand R; Feeley B; Niedbala RS
J Anal Toxicol; 1999 Oct; 23(6):429-35. PubMed ID: 10517547
[TBL] [Abstract][Full Text] [Related]
4. Detection of flunitrazepam and 7-aminoflunitrazepam in oral fluid after controlled administration of rohypnol.
Samyn N; De Boeck G; Cirimele V; Verstraete A; Kintz P
J Anal Toxicol; 2002; 26(4):211-5. PubMed ID: 12054361
[TBL] [Abstract][Full Text] [Related]
5. Urinary detection times and excretion patterns of flunitrazepam and its metabolites after a single oral dose.
Forsman M; Nyström I; Roman M; Berglund L; Ahlner J; Kronstrand R
J Anal Toxicol; 2009 Oct; 33(8):491-501. PubMed ID: 19874658
[TBL] [Abstract][Full Text] [Related]
6. A sensitive immunoassay for flunitrazepam and metabolites.
Walshe K; Barrett AM; Kavanagh PV; McNamara SM; Moran C; Shattock AG
J Anal Toxicol; 2000; 24(4):296-9. PubMed ID: 10872578
[TBL] [Abstract][Full Text] [Related]
7. Extraction and analysis of flunitrazepam/7-aminoflunitrazepam in blood and urine by LC-PDA and GC-MS using butyl SPE columns.
Hackett J; Elian AA
Forensic Sci Int; 2006 Mar; 157(2-3):156-62. PubMed ID: 15955650
[TBL] [Abstract][Full Text] [Related]
8. Improved screen and confirmation test of 7-aminoflunitrazepam in urine specimens for monitoring flunitrazepam (Rohypnol) exposure.
Wang PH; Liu C; Tsay WI; Li JH; Liu RH; Wu TG; Cheng WJ; Lin DL; Huang TY; Chen CH
J Anal Toxicol; 2002 Oct; 26(7):411-8. PubMed ID: 12422994
[TBL] [Abstract][Full Text] [Related]
9. Serum and urine concentrations of flunitrazepam and metabolites, after a single oral dose, by immunoassay and GC-MS.
Snyder H; Schwenzer KS; Pearlman R; McNally AJ; Tsilimidos M; Salamone SJ; Brenneisen R; ElSohly MA; Feng S
J Anal Toxicol; 2001; 25(8):699-704. PubMed ID: 11765027
[TBL] [Abstract][Full Text] [Related]
10. [Determination of 7-aminoflunitrazepam, the major metabolite of flunitrazepam in urine by high performance thin-layer chromatography].
Wu YH; Tan JY; Xia Y
Se Pu; 2002 Mar; 20(2):182-4. PubMed ID: 12541981
[TBL] [Abstract][Full Text] [Related]
11. Rapid method for the solid-phase extraction and GC-MS analysis of flunitrazepam and its major metabolites in urine.
Nguyen H; Nau DR
J Anal Toxicol; 2000; 24(1):37-45. PubMed ID: 10654568
[TBL] [Abstract][Full Text] [Related]
12. Flunitrazepam excretion patterns using the Abuscreen OnTrak and OnLine immunoassays: comparison with GC-MS.
Salamone SJ; Honasoge S; Brenner C; McNally AJ; Passarelli J; Goc-Szkutnicka K; Brenneisen R; elSohly MA; Feng S
J Anal Toxicol; 1997 Sep; 21(5):341-5. PubMed ID: 9288585
[TBL] [Abstract][Full Text] [Related]
13. Identification of urinary benzodiazepines and their metabolites: comparison of automated HPLC and GC-MS after immunoassay screening of clinical specimens.
Valentine JL; Middleton R; Sparks C
J Anal Toxicol; 1996 Oct; 20(6):416-24. PubMed ID: 8889678
[TBL] [Abstract][Full Text] [Related]
14. Performance characteristics of 7-aminoflunitrazepam specific enzyme-linked immunosorbent assays.
Lin DL; Yin RM; Chen CH; Chen YL; Liu RH
J Anal Toxicol; 2005 Oct; 29(7):718-23. PubMed ID: 16419407
[TBL] [Abstract][Full Text] [Related]
15. Benzodiazepines in Miami-Dade County, Florida driving under the influence (DUI) cases (1995-1998) with emphasis on Rohypnol: GC-MS confirmation, patterns of use, psychomotor impairment, and results of Florida legislation.
Raymon LP; Steele BW; Walls HC
J Anal Toxicol; 1999 Oct; 23(6):490-9. PubMed ID: 10517556
[TBL] [Abstract][Full Text] [Related]
16. Acute intoxication caused by overdose of flunitrazepam and triazolam: high concentration of metabolites detected at autopsy examination.
Namera A; Makita R; Saruwatari T; Hatano A; Shiraishi H; Nagao M
Am J Forensic Med Pathol; 2012 Dec; 33(4):293-6. PubMed ID: 21372658
[TBL] [Abstract][Full Text] [Related]
17. The detection and quantitation of 7-aminoflunitrazepam, the major urinary metabolite of flunitrazepam, by gas chromatography/mass spectrometry.
Feely J; Kavanagh PV; McNamara SM
Ir J Med Sci; 1999; 168(3):189-92. PubMed ID: 10540786
[TBL] [Abstract][Full Text] [Related]
18. Characterization and evaluation of two-dimensional microfluidic chip-HPLC coupled to tandem mass spectrometry for quantitative analysis of 7-aminoflunitrazepam in human urine.
Bai HY; Lin SL; Chan SA; Fuh MR
Analyst; 2010 Oct; 135(10):2737-42. PubMed ID: 20820494
[TBL] [Abstract][Full Text] [Related]
19. Determination of flunitrazepam and its main metabolites in serum and urine by HPLC after mixed-mode solid-phase extraction.
Deinl I; Mahr G; von Meyer L
J Anal Toxicol; 1998; 22(3):197-202. PubMed ID: 9602935
[TBL] [Abstract][Full Text] [Related]
20. Development of immunoaffinity solid phase microextraction probes for analysis of sub ng/mL concentrations of 7-aminoflunitrazepam in urine.
Lord HL; Rajabi M; Safari S; Pawliszyn J
J Pharm Biomed Anal; 2006 Feb; 40(3):769-80. PubMed ID: 16352414
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
